Trials & Tribulations Protecting the cure: Why the future of radiation oncology must be precision-guided April 10, 2026Vol.52 No.14By J. Isabelle Choi
News Analysis HHS presents new protein-forward dietary guidelines, turning the food pyramid upside downThe Kennedy guidelines are mum on cancer risks associated with red meat and alcohol April 03, 2026Vol.52 No.13By Claire Marie Porter
Free Ukrainian oncologists press on in year four of wartime disruptionsAmid missiles and blackouts, “you cannot put your life on a pause forever.” April 03, 2026Vol.52 No.13By Sara Willa Ernst
FreeGuest Editorial FDA’s guidance on MRD in MM goes beyond the ODAC vote—and that’s where it matters mostDraft guidance consolidates trial design updates for developers April 03, 2026Vol.52 No.13By Nicholas Richardson
Editorial The Cancer Letter Podcast nominated for 30th annual Webby Awards April 03, 2026Vol.52 No.13By Paul Goldberg and Jacquelyn Cobb
PodcastThe Directors The Directors: Wistar’s Altieri and ChristianaCare’s Petrelli say partnership of their institutions will go on as the guard changes March 27, 2026Vol.52 No.12By Sara Willa Ernst and Paul Goldberg
FreeTrials & Tribulations Early-onset cancer is on the rise. Here is how OSUCCC–James is adapting to the needs of younger patients March 27, 2026Vol.52 No.12By W. Kimryn Rathmell
Trials & Tribulations In the era of immunotherapy, response rate alone fails to predict true patient benefitRegulators must adapt March 27, 2026Vol.52 No.12By Richard M. Goldberg
Colorectal cancer is now the leading cause of cancer death in patients under 50Why aren’t 45-year-olds getting their recommended CRC screenings? March 27, 2026Vol.52 No.12By Sara Willa Ernst
FreeObituary Michael Bishop, Nobel-winning cancer researcher, dies at 90 March 27, 2026Vol.52 No.12By UCSF Communications Staff
